Shariah compliance overview
Not HalalJanux Therapeutics, Inc. (JANX) is currently classified as Not Halal by Akinda Shariah screening (AAOIFI-aligned methodology).
About Janux Therapeutics, Inc.
Janux Therapeutics, Inc. is a biopharmaceutical company dedicated to developing innovative cancer therapies. The firm leverages its proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to create treatments designed to activate the body's T cells to fight tumors.
Janux Therapeutics, Inc. (JANX) operates in the Healthcare sector, in the Biotechnology industry.
Why it is not classified as halal: it does not pass these screens: Business Activity, Interest-bearing securities and assets.
- Business Activity
- 81.50%Limit 5%Fail
- Interest-bearing debt
- 0.16%Limit 30%Pass
- Interest-bearing securities and assets
- 65.35%Limit 30%Fail
- Dividend purification
- 81.50%Share of dividends to give to charityPurification calculator
Last updated: Nov 3, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.
Please login to access this content
Please login to access this content
Please login to access this content
Company Profile
Please login to access this content
Frequently asked questions
Quick answers about Janux Therapeutics, Inc. (JANX). Current Akinda screening label: Not Halal.
